可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Bruckner BA, Razeghi P, Stetson S, et al. Degree of cardiac fibrosis and hypertrophy at time of implanutation predicts myocardial improvement during left ventricular assist device support[J]. J Heart Lung Transplant, 2004, 23(1):36-42.
[2] Tarone G, Guido G. Molecular interplay between mechanical and humoral signaling in cardiac hypertrophy[J]. Trends Mol Med, 2003, 9(9):376-382.
[3] Rona G, Chappel CI, Balazs T, et al. An infactlike myocardial lesion and other toxic manifestations produced by isoproterenol in the rat\[J\]. AMA Arch Pathol, 1959, 67(4):443-455.
[4] Acharya Dhan Kumar, 党瑜华. 曲美他嗪在缺血性心脏病中的应用[J]. 中国临床药理学与治疗学, 2006, 11(4):385-391.
[5] 赵艳芳, 秦永文, 王学敏, 等. 曲美他嗪对大鼠缺血再灌注心肌线粒体的保护作用[J]. 中国动脉硬化杂志 , 2005, 13(2):171-174.
[6] 徐静,何作云,冯兵,等. 曲美他嗪对肥大心肌细胞缺氧复氧的抗凋亡作用[J]. 重庆医学, 2006, 35(10):909-911,913.